SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1.66 Cr | ₹5.21 Cr | ₹4.97 Cr | - | - |
What is the latest Contingent Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹1.66 Cr |
| Mar2025 | ₹5.21 Cr |
| Mar2024 | ₹4.97 Cr |
| Mar2020 | - |
| Mar2019 | - |
How is Contingent Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.66 Cr | -68.14 | |
| Mar2025 | ₹5.21 Cr | 4.87 | |
| Mar2024 | ₹4.97 Cr | 0 | |
| Mar2020 | - | 0 | |
| Mar2019 | - | - | |
Compare Contingent Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹912.6 Cr | 4.2% | 15.1% | 19.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 4.2% |
15.1% |
19.3% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses